Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Provir effective in patients with travelers' diarrhea

Aug. 30, 1996

FDA approves Helidac for marketing

Aug. 30, 1996

Hepatitic C infection drug discovery alliance formed

Aug. 23, 1996

Tritec approved for U.S. market

Aug. 23, 1996

HemoCleanse, VivoRx to collaborate on bioartificial liver device

Aug. 16, 1996

Hepagene efficacy confirmed in phase III

Aug. 16, 1996

Zadaxin filing in Taiwan appears imminent

Aug. 16, 1996

BXT-51072 in phase I clinical trials

Aug. 16, 1996

U.S. patent reinforces OraVax's UreAB development position

Aug. 16, 1996

Novopharm states intention to market generic ranitidine

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...